Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I N Bruce

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Postgraduate Medical Journal|January 1, 1995
Chronic suppurative lung disease with associated vasculitisI N Bruce, J A McAteer, P V Gardiner, et al.
The Journal of Rheumatology|December 29, 2000
Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature reviewI N Bruce, C A Clark-Soloninka, K A Spitzer, et al.
Rheumatology (Oxford, England)|October 25, 2007
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritisY Bravo Vergel, N S Hawkins, K Claxton, et al.
Arthritis Care & Research|May 5, 2012
Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterJ H Humphreys, S M M Verstappen, H Mirjafari, et al.
Lupus|March 4, 2016
Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of careI N Bruce, M Urowitz, R van Vollenhoven, et al.
Lupus|December 17, 2009
Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosusZ Barta, M J Harrison, T Wangrangsimakul, et al.
Rheumatology (Oxford, England)|March 27, 2007
Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotypeY Ahmad, J Shelmerdine, H Bodill, et al.
BBA Clinical|January 6, 2017
Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue diseaseE M McCarthy, D Moreno-Martinez, F L Wilkinson, et al.
Lupus|December 21, 2013
The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive diseaseM A Khamashta, I N Bruce, C Gordon, et al.
Annals of the Rheumatic Diseases|August 31, 2007
Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritisP Y P C Ho, A Barton, J Worthington, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Postgraduate Medical Journal|January 1, 1995
Chronic suppurative lung disease with associated vasculitisI N Bruce, J A McAteer, P V Gardiner, et al.
The Journal of Rheumatology|December 29, 2000
Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature reviewI N Bruce, C A Clark-Soloninka, K A Spitzer, et al.
Rheumatology (Oxford, England)|October 25, 2007
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritisY Bravo Vergel, N S Hawkins, K Claxton, et al.
Arthritis Care & Research|May 5, 2012
Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterJ H Humphreys, S M M Verstappen, H Mirjafari, et al.
Lupus|March 4, 2016
Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of careI N Bruce, M Urowitz, R van Vollenhoven, et al.
Lupus|December 17, 2009
Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosusZ Barta, M J Harrison, T Wangrangsimakul, et al.
Rheumatology (Oxford, England)|March 27, 2007
Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotypeY Ahmad, J Shelmerdine, H Bodill, et al.
BBA Clinical|January 6, 2017
Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue diseaseE M McCarthy, D Moreno-Martinez, F L Wilkinson, et al.
Lupus|December 21, 2013
The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive diseaseM A Khamashta, I N Bruce, C Gordon, et al.
Annals of the Rheumatic Diseases|August 31, 2007
Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritisP Y P C Ho, A Barton, J Worthington, et al.
Pageof 7